Asperger Syndrome: Clinical Trials

6 trials for Asperger Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 5, Unknown 1

Follow Asperger Syndrome: new trials by email Literature Review of Asperger Syndrome trials Research Report on Asperger Syndrome

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD
Methylphenidate extended-release liquid formulation - Attention-deficit/Hyperactivity Disorder, Autism Spectrum Disorder
Phase 4CompletedMassachusetts General Hospital152014-05-012024-07-01
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
Gammaplex 5% - Autism, Autistic Disorder
Phase 4UnknownIsaac Melamed302013-06-012015-04-16
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
placebo, extended-release guanfacine - Pervasive Development Disorders
Phase 4CompletedYale University622011-12-012020-03-31
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Milnacipran, Placebo - Autism Spectrum Disorder, Asperger Syndrome
Phase 4CompletedMontefiore Medical Center102011-02-012020-02-27
Atomoxetine, Placebo and Parent Management Training in Autism
atomoxetine, Placebo, Parent Management Training - Autism, Pervasive Development Disorder
Phase 4CompletedUniversity of Rochester1282008-10-012016-02-04
Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study
Risperidone, Magnetic Resonance Spectroscopy - Asperger's Disorder
Phase 4CompletedAugusta University232001-11-012015-01-14

Narrower conditions

Autistic Disorder (4)  ·  Attention Deficit Disorder with Hyperactivity (3)  ·  Child Development Disorders, Pervasive (3)  ·  Autism Spectrum Disorder (2)  ·  Social Skills (1)  ·  Spasm (1)

Broader conditions

Mental Disorders (6)  ·  Neurodevelopmental Disorders (6)  ·  Autism Spectrum Disorder (4)  ·  Attention Deficit and Disruptive Behavior Disorders (3)  ·  Child Development Disorders, Pervasive (3)  ·  Behavior (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Social Behavior (1)

Interventions

Atomoxetine Hydrochloride (1)  ·  Guanfacine (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Milnacipran (1)  ·  Risperidone (1)

Sponsors

Augusta University (1)  ·  Isaac Melamed (1)  ·  Massachusetts General Hospital (1)  ·  Montefiore Medical Center (1)  ·  University of Rochester (1)  ·  Yale University (1)

Countries

United States (6)

Top investigators

Benjamin Handen, PhD (1)  ·  Bryan King, MD (1)  ·  Christopher McDougle, MD (1)  ·  Donna L Londino, MD (1)  ·  Eric Hollander, MD (1)  ·  Gagan Joshi, MD (1)  ·  Isaac Melamed, MD (1)  ·  James Dziura, MPH, PhD (1)  ·  James McCracken, MD (1)  ·  Jeffrey L Rausch, MD (1)  ·  Lawrence Scahill, MSN, PhD (1)  ·  Michael Aman, PhD (1)  ·  Tristram Smith, PhD (1)

Results publications

PMID 37811711, PMID 20377705, PMID 26506581, PMID 27663942, PMID 29022125, PMID 29694241, PMID 31607204

NIH funding

R01MH083707 (1)